India has 254 million obese people and over 100 million with diabetes, according to a Lancet study from 2023. Plus, 351 million people suffer from abdominal obesity, while 136 million people are pre-diabetic, making the addressable market massive for these drugs.
Recent Posts
- Bitcoin, Ethereum, XRP, Dogecoin Fall, While Oil Surges Amid Middle East War: Analytics Firm Says BTC Is ‘Still In A Bear Market’
- Smallcap Stock Shows Bullish Reversal After Forming Inverted Head-and-Shoulders Pattern
- NBCC and 5 Other Nifty 500 Stocks Trading Below RSI 30; Do You Hold Any?
- Microsoft says Anthropic’s products remain available to customers after Pentagon blacklist
- Iran War Live Updates: No Plans To Pursue A Ceasefire, Says Iran; Ukraine Agrees To Assist US And Allies